Cardon Bio SA
Cardon Bio reported total assets of 324,561 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of Cardon Bio shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +72 % Total assets +345 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cardon Bio's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
Cardon Bio's financial analysis
- Solvency27.2%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cardon Bio
Cardon Bio's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0782.633.810
- VAT number
- BE0782633810
- Peppol
- Registered · 0208:0782633810 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Feb 2022
- Registered office
- 9052 Ghent
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Cardon Bio (SA) has been based in Ghent since 2022, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 17,508 € and equity of 88,397 €; its revenue is not published. Its solvency stands at 27.2%, below the median of its sector (47.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cardon Bio
Companies in the same business, of comparable size and area, outside its group.
- Arterix Retail sale of medical and orthopaedic goods Destelbergen · balance sheet 9,206 €
- Glano Retail sale of medical and orthopaedic goods Merelbeke-Melle · balance sheet 290,512 €
- Sol Scientifics Retail sale of medical and orthopaedic goods Ghent · balance sheet 426,554 €
- S-Sense Retail sale of medical and orthopaedic goods Ghent · balance sheet 444,654 €
- B&O Retail sale of medical and orthopaedic goods Sint-Martens-Latem · balance sheet 249,098 €
- GP Audiologie Retail sale of medical and orthopaedic goods Anthisnes · balance sheet 439,670 €
- Optopolis Retail sale of medical and orthopaedic goods Tongeren · balance sheet 322,654 €
- Hoorcentrum Liesje De Wit Retail sale of medical and orthopaedic goods Leuven · balance sheet 328,664 €
Frequently asked questions about Cardon Bio
What is the revenue of Cardon Bio?
Cardon Bio files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cardon Bio?
In Belgium, the VAT number is the company number prefixed with BE: BE0782633810 for Cardon Bio, if the company is VAT-registered. Its company number (CBE) is 0782.633.810.
Where is the registered office of Cardon Bio?
According to the CBE register, the registered office of Cardon Bio is in 9052 Ghent.
What is the equity of Cardon Bio?
At the close of the 2025 financial year, the equity of Cardon Bio amounts to 88,397 €, a solvency of 27.2% of total assets.
Who manages Cardon Bio?
The register lists 5 active mandates at Cardon Bio. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cardon Bio
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →